Overview
Northern Bio is a preclinical CRO that specializes in targeted drug delivery, molecular biology, and bioanalysis to develop safe and effective treatments for devastating diseases. Using advanced surgical techniques and research, we maximize therapeutic impact.
Our expertise is in in-vivo non-GLP and GLP safety assessment solutions for novel therapeutics using advanced surgical techniques. Our Bioanalysis group focuses on advanced molecular biological techniques and ligand binding assays. We collaborate closely with our clients to develop customized preclinical studies to facilitate regulatory approval.
Find out more about our services: